Add onc brain to your Home Screen: tap Share, then Add to Home Screen.
SWOG S1827/MAVERICK: MRI surveillance alone beat MRI + PCI for CFFS, HR 0.60 (90% CI 0.46-0.78), in LS- and ES-SCLC without brain mets; OS immature.
Thoracic, CNS and prostate RT led. MAVERICK favors MRI surveillance over PCI in SCLC on cognition, OS still immature. ROADS Cs-131 tile brachytherapy cut surgical bed recurrence vs cavity SRT (time-to-SBR HR 0.06). STOP adds SBRT to iADT in PSMA-detected oligomets (3-yr biochemical progression 21% vs 60%); PACE-A (GG1-2): more pad use after RP than SBRT, only 13 BCF events.
read the full digest →Studies · 139
- SWOG S1827/MAVERICKMRI surveillance alone beat MRI + PCI for cognitive failure-free survival, HR 0.60 (90% CI 0.46-0.78), in LS- and ES-SCLC without brain mets after first-line therapy.
- PACE-A≥1 urinary pad 14/29 (48%) RP vs 3/36 (8%) SBRT; BCF HR 0.48 (95% CI 0.16-1.46), mFU 8 yrs, GG1-2 localised PCa.
- STOP3-yr biochemical progression 21% vs 60% (p=0.004) adding SBRT to intermittent ADT in PSMA PET-detected, conventional-imaging-negative oligometastatic HSPC/BCR.
- ROADSCs-131 tile brachytherapy at resection cut surgical bed recurrence vs post-op SRT: time-to-SBR HR 0.06 (0.01-0.46), SB-RFS HR 0.48, in newly diagnosed resected brain mets.
- LAVA-CRLM1-yr freedom from local progression 83.0% SBRT vs 77.7% MWA (HR 0.87, p=0.70); treatment-related G2+ toxicity 3% vs 25% in oligometastatic CRLM.
- ROAM/EORTC-1308Adjuvant IMRT 60 Gy/30 fx vs observation after complete resection of WHO grade 2 atypical meningioma: DFS HR 0.51 (0.27–0.97); 5-yr DFS 79.9% vs 64.3%.
- BIG 3-07/TROG 07.01Tumour bed boost after WBI in resected non-low-risk DCIS: 5-yr freedom from LR 97.1% vs 92.7%, HR 0.47 (0.31-0.72), p<0.001.
- Testosterone Treatment in Prostate Cancer Survivors (Bhasin RCT)Sexual activity +0.91 daily events vs placebo (95% CI 0.56-1.26, P<.001), zero biochemical recurrences, 12wk TRT in hypogonadal men post-RP for Gleason 3+3/3+4.
- ASTRO Clinical Practice Guideline: RT for Bladder CancerTMT recommended (strong, high QoE) as alternative to RC for select cT2-4aN0M0 MIBC; bladder-alone 5500 cGy/20 fx or 6400-6480 cGy/32-36 fx.
- Gamma Knife vs LINAC-based radiosurgery for vestibular schwannoma (retrospective review)Local control 98.8%; no difference in new vertigo, gait disturbance or facial palsy with GKRS (n=36) vs LINAC (n=49) SRS for vestibular schwannoma.
- SWOG S1827/MAVERICKRandomized phase III, LS or ES SCLC: PCI 25 Gy/10 fx + MRI vs MRI surveillance alone; no CFFS or OS results in source tweets.
- TORPEdO18% vs 7% 12-mo G-tube dependence/≥20% weight loss (p=0.079), UW-QoL 78.3 vs 77.1 (p=0.56): IMPT not superior to IMRT, locally advanced oropharyngeal SCC.